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Summary
The genetic mechanisms involved in sex differentiation
are poorly understood, and progress in identification of
the genes involved has been slow. The fortuitous finding
of chromosomal rearrangements in association with a
sex-reversed phenotype has led to the isolation of SRY
and SOX9, both shown to be involved in the sex-de-
termining pathway. In addition, duplications of the X
chromosome, deletions of chromosomes 9 and 10, and
translocations involving chromosome 17 have been re-
ported to be associated with abnormal testicular differ-
entiation, leading to male-to-female sex reversal in
46,XY individuals. We present the cytogenetic and mo-
lecular analyses of four sex-reversed XY females, each
with gonadal dysgenesis and other variable malforma-
tions, and with terminal deletions of distal chromosome
9p, resulting from unbalanced autosomal translocations.
PCR amplification and DNA sequence analysis of SRY
revealed no mutations in the high-mobility-group do-
main (i.e., HMG box) in any of the four patients. Con-
ventional and molecular cytogenetic analyses of meta-
phase chromosomes from each patient suggest that the
smallest region of overlap (SRO) of deletions involves a
very small region of distal band 9p24. Loss-of-heterozy-
gosity studies using 17 highly polymorphicmicrosatellite
markers, as well as FISH using YAC clones correspond-
ing to the most distal markers on 9p, showed that the
SRO lies distal to marker D9S1779. These results sig-
nificantly narrow the putative sex-determining gene to
the very terminal region of the short arm of chro-
mosome 9.
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Introduction
Phenotypic females with an XY chromosome constitu-
tion, who exhibit ambiguous genitalia or complete go-
nadal dysgenesis, occur with a frequency of ∼1/20,000
births (Robinson and Linden 1993) and often present
as both medical and social emergencies. Not only do
such abnormalities lead to recognition of other poten-
tially serious birth defects and long-term medical prob-
lems, but the failure to promptly resolve the question of
gender at birth may lead to a family psychosocial crisis
relative to the sex of rearing. At puberty these individuals
are typically deficient in secondary sex characteristics,
have primary amenorrhea, and tend to be taller than XX
females, yet, despite the presence of only a single X chro-
mosome, they lack the stigmata of a Turner syndrome
phenotype. Gynecological evaluation has shown that go-
nadal dysgenesis may present with a wide spectrum of
findings, ranging from individuals with either testicular
tissue on one side and a streak gonad on the other or
bilateral streak gonads, although internal sex organs are
most often female. In the presence of the Y chromosome,
these individuals are at a significant (30%) risk for the
development of malignant gonadoblastoma, and early
gonadectomy is recommended (Sultana et al. 1995). XY
sex reversal occasionally has been reported to occur
in families in a manner suggestive of X-linked reces-
sive inheritance, but sporadic occurrences are more
common.
Progress in our understanding of sex differentiation
and development, as well as the identification of genetic
loci involved, has been slow. The identification of chro-
mosomal rearrangements found in association with a
sex-reversed phenotype has led to the isolation of two
genes, SRY (sex determining region, Y chromosome)
(Sinclair et al. 1990) and SOX9 (SRY-related box gene
9) (Foster et al. 1994; Wagner et al. 1994), both shown
to be involved in the sex-determining pathway. Muta-
tions in SOX9 have been observed in XY females with
campomelic dysplasia (Foster et al. 1994; Wagner et al.
1994; Kwok et al. 1995; Meyer et al. 1997), and mu-
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tations in SRY have been identified in a relatively small
number (15%) of XY females (Berta et al. 1990; Jager
et al. 1990; Hawkins et al. 1992; Affara et al. 1993;
Cameron and Sinclair 1997). These findings suggest that
sex reversal in the majority of cases involves alterations
of other genetic loci.
In humans, several visible cytogenetic alterations have
been associated with various sex-reversal syndromes, in-
dicating not only the presence of other sex-determining
genes, but also clues as to their location. Duplications
of band Xp21 have been shown to be associated with
XY-female development (Bernstein et al. 1980), sug-
gesting the presence, on the X chromosome, of a region
called “DSS” (dosage-sensitive sex reversal), mapped to
a 160-kb region at Xp21 (Bardoni et al. 1994). In ad-
dition to SOX9, mapped to 17q24.3-q25.1 (Tommerup
et al. 1993), two other autosomal loci also have been
implicated in XY sex reversal. Deletions of loci on chro-
mosomal regions 10q (Wilkie et al. 1993) and 9p (Jot-
terand and Julliard 1976; Fryns et al. 1986; Hoo et al.
1989; Crocker et al. 1988; Magenis et al. 1990; Bennett
et al. 1993; McDonald et al. 1997; Ogata et al. 1997)
also can result in XY females with gonadal dysgenesis,
suggesting that these chromosomes also harbor genes
involved in sex determination. Of eight previously re-
ported cases of 9p, six showed concurrent loss of 9p
and duplication of different chromosomal regions, re-
sulting from familial or de novo chromosome translo-
cations (Jotterand and Julliard 1976; Fryns et al. 1986;
Crocker et al. 1988; Hoo et al. 1989; Magenis et al.
1990; McDonald et al. 1997). Two cases showed ter-
minal de novo deletions (Bennett et al. 1993; Ogata et
al. 1997). In most cases, the patients exhibit sex reversal
with normal-appearing female external genitalia in ad-
dition to varying degrees of gonadal dysgenesis and
other phenotypic malformations. Among those individ-
uals, the most proximal breakpoint reported is at 9p21,
and the most distal is at 9p24. These data suggest that
a gene(s) located within band 9p24 is involved in the
production of a normal male testis. In this study, we
have obtained lymphoblastoid cell lines from two pre-
viously reported patients (Hoo et al. 1989; McDonald
et al. 1997) and two previously unreported patients with
complete or partial sex reversal and 9p monosomy, who
also have duplications of other autosomal regions. Con-
ventional and molecular cytogenetic characterization of
these cell lines, in addition to loss of heterozygosity
(LOH) studies using 17 highly polymorphic microsat-
ellite markers, have localized the smallest region of over-
lap (SRO) distal to marker D9S1779 within band
9p24.3. These results further define the minimum 9p
critical region that harbors a gene involved in male sex
determination.
Patients and Methods
Patients and Cytogenetic Analysis
Case 7, a normal female at birth, with no immediate
physical or developmental findings, was referred for
evaluation of a previously identified familial chromo-
somal translocation. Family history revealed recurrent
miscarriages. Karyotype analysis of the proband’s father
and his twin brother showed a balanced translocation
between chromosomes 8 and 9. Their karyotypes were
designated 46,XY,t(8;9)(p21;p24). The clinical and cy-
togenetic evaluation of this patient has been reported
elsewhere (McDonald et al. 1997). In brief, at 3 years
of age she had no noticeably dysmorphic features but
demonstrated mild developmental delays inmajormotor
development and expressive-language development.
Routine G-band analysis revealed a male 46,XY chro-
mosome complement, in addition to a derivative chro-
mosome 9 (der[9] chromosome) in which the distal short
arm of one homologue appeared to include additional
genetic material of undefined origin. Her karyotype was
determined to be 46,XY,der(9)t(8;9) (p21;p24)pat, in-
dicating that she is monosomic for the distal portion of
chromosome 9p24 and trisomic for the p arm of chro-
mosome 8 bands p21-pter. FISH analysis, using a chro-
mosome 9–specific paint probe, confirmed these findings
in both the proband and her father (McDonald et al.
1997). In view of her XY sex-chromosome constitution,
she was evaluated by pelvic ultrasound. Examination
showed female internal structures including a uterus and
vagina; gonads were not identified. Levels of both fol-
licle-stimulating hormone and luteinizing hormone were
elevated, suggesting that she has ovarian dysgenesis. She
has since undergone a complete gonadectomy because
of an increased risk for the development of gonado-
blastoma.
Case 8 was a full-term infant ascertained for trache-
oesophageal fistula and complex congenital heart dis-
ease. Physical examination revealed multiple anomalies,
including short palpebral fissures, broad nasal bridge
with telecanthus, mild micrognathia, short neck with
redundant skin, and choanal atresia. The patient’s chest
was asymmetrical, with the right side larger than the left
and with slight pectus excavatum. The heart showed a
ventricular septal defect, coarctation of the aorta, and a
hypoplastic left ventricle. She also had bilateral hydro-
nephrosis with hydroureters, normal female external
genitalia, and a uterus. Other findings included syndac-
tyly of the third and fourth toes, hyperextensibility of
the joints, and mild hypotonia. Chromosome analysis
revealed both a der(9) chromosome showing loss of dis-
tal 9p and additional material thought to be derived
from chromosome 15. Her karyotype was designated
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46,XY,der(9),t(9;?15)(p22;?q22.3). Subsequent FISH
analysis using a chromosome 9–specific paint probe con-
firmed that the translocation involved chromosome 9,
but no signal was observed on the der(9) chromosome
when a chromosome 15 paint probe was used.
Case 9 presented, at birth, with ambiguous exter-
nal genitalia and respiratory distress. Dysmorphol-
ogy evaluation revealed hypotonia, micrognathia, mi-
crosomia, long philtrum, short nose with prominent
alae, a short neck, and wide-set nipples. The external
genitalia consisted of hyperpigmented, fused labioscrotal
folds, extreme microphallus, and small palpable testes.
There was a small urethral opening at the base of the
phallus, with a normal anus. A pelvic examination
showed normal kidneys, adrenals, and bladder, with no
uterine structures. Karyotype analysis revealed a
46,XY,der(9)t(9;11)(p24;q14.2) chromosome comple-
ment. Subsequent cytogenetic studies of parental blood
samples showed that the mother is a carrier of a bal-
anced reciprocal translocation involving chromosomes
9 and 11. The proband’s karyotype was designated
46,XY,der(9)t(9;11)(p24;q14.2)mat. FISH analysis with
chromosome 9–specific and chromosome 11–specific
paint probes confirmed involvement of these two
chromosomes.
Case 4 has been published elsewhere (Hoo et al.
1989). The clinical details on this child have not been
described completely, although she was reported to have
multiple congenital anomalies, including normal female
external genitalia and the presence of a vagina. Previous
analysis of the patient’s chromosomes revealed a
46,XY,der(9),t(2;9)(p21;p24) karyotype. This cell line
was obtained through the National Institute of General
Medical Sciences’ Human Genetic Mutant Cell Repos-
itory (Camden, NJ) (repository number GM12896). G-
banding and FISH with chromosome 2–specific and
chromosome 9–specific paint probes confirmed the cy-
togenetic findings.
SRY Analysis
Genomic DNA samples from each patient and from
normal male and female controls were used as templates
to PCR-amplify the entire high-mobility group (HMG)
domain of SRY. Primer sets used in the PCR have been
reported elsewhere (Affara et al. 1993) and includeXES2
and XES7, which synthesizes a 609-bp fragment that
spans both the entire HMG domain of the SRY gene
and flanking sequences. For each DNA sample, duplicate
PCR reactions were performed at 94C for 5 min, fol-
lowed by 35 cycles each of 94C for 1 min, 68C for 2
min, and 72C for 3 min. PCR products were analyzed
on 1% agarose gels. Amplified fragments subsequently
were isolated, purified, and sequenced by means of M13
forward and reverse nested primers, SRY3 and SRY6,
which flank a 269-bp region of the HMG domain of the
SRY gene. The resulting double-strand DNA templates
were sequenced directly from both ends by means of the
dsDNA Cycle Sequencing System (Gibco/BRL). Se-
quence reactions were run on 6% denaturing polyacryl-
amide gels and were autoradiographed overnight. Pa-
tient SRY sequences were compared with those of
normal male control samples.
FISH
Hybridization protocols have been reported elsewhere
(Flejter et al. 1993, 1995). YAC clones corresponding
to markers D9S1858, D9S1779, and D9S1813 were hy-
bridized to metaphase cells from case 7 and her father.
A chromosome 9–specific centromere probe was used as
a control for each hybridization. Slides were visualized
on a standard fluorescence microscope equipped with
the appropriate epifluorescence optics. Photographs
were taken with an Olympus microscope equipped with
a Photometrics CCD camera. Images were produced by
Vysis Imaging Software.
Microsatellite Studies
Amplification of genomic DNA from each patient was
performed according to the specific methods reported
for each oligonucleotide pair. Primer sequences and the
PCR conditions are as described in the references given
in table 1. Typically, one primer was end-labeled with
[32P]-dATP, and PCR was performed for 25–35 cycles,
with 30–50 ng of DNA in a 25-ml reaction volume under
recommended amplification conditions. A portion of
each amplified DNA sample was denatured and sepa-
rated on 6%–8% denaturing polyacrylamide gels at
200–300 V for 3–6 h, depending on the fragment size.
Gels were exposed to Kodak XAR-5 film for 4–6 h. Each
set of reactions also contained DNA from three CEPH
individuals (K884-01, K1347-8408, and K1362-8574),
as standard controls.
Results
Conventional and molecular cytogenetic analyses of
the cell lines derived from each of four sex-reversed in-
dividuals showed breakpoints in chromosome 9p, span-
ning deletions ranging from band 9p22 to band 9p24,
indicating that the smallest region of deletion—and,
hence, the putative sex-determining gene—lies within
band 9p24 (table 2).
To rule out the possibility that sex reversal in our
patients is not due to alterations in the conserved region
of SRY but, rather, results from a deletion on distal 9p,
mutation analysis of the SRY HMG domain was per-
formed. In these studies, genomic DNA from each 9p
cell line and from normal male and female controls was
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Table 1
Microsatellite Analysis of Sex-Reversed 9p Patients
LOCUS
GENOTYPE OFa
NO. OF
ALLELES
HETERO-
ZYGOSITY REFERENCEbCase 7 Father Mother Case 8 Case 9 Case 4
D9S1858 2,2 1,2 1,2 2,2 2,2 2,2 3 58 Dib et al. (1996)
D9S1779 2,– 3,4 2,4 4,4 1,1 2,2 8 63 Dib et al. (1996)
D9S1813 4,6 4,6 2,6 1,1 2,2 5,5 13 83 Dib et al. (1996)
D9S1871 4,6 4,6 2,6 1,1 2,2 5,5 7 68 Dib et al. (1996)
D9S143 1, 2 1, 1 1,2 2,2 1,1 1,1 8 54 Furlong et al. (1992)
D9S230 2,3 2,5 1,3 5,5 4,4 2,2 4 67 Wilkie et al. (1992)
D9S54 1,2 2,2 1,5 1,1 1,1 1,1 8 54 UMDG
D9S178 1,2 1,2 1,2 1,1 3,3 2,2 4 68 Dib et al. (1996)
D9S286 3,6 1,6 3,4 3,5 1,5 2,6 12 87 Dib et al. (1996)
D9S168 1,2 2,2 1,2 2,2 3,3 1,4 9 75 Dib et al. (1996)
D9S235 2,2 2,2 1,2 1,2 1,2 1,2 2 63 Dib et al. (1996)
D9S285 2,2 2,2 2,2 1,3 2,2 4,5 9 79 UMDG
D9S156 1,2 2,2 1,2 1,4 2,3 1,2 15 79 Dib et al. (1996)
D9S162 1,7 7,7 1,2 1,2 2,2 2,2 10 72 Dib et al. (1996)
D9S171 1,6 ) ) 9 79 Dib et al. (1996)
D9S770 2,3 3,4 1,2 1,3 1,2 1,4 2 10 UMDG
D9S232 1,4 2,4 1,3 1,4 1,2 3,4 7 63 UMDG
a Underlining denotes that LOH is suggested.
b UMDG  The Utah Marker Development Group (1995).
used as template to PCR-amplify both the entire HMG
domain and flanking sequences of SRY. Gel electropho-
resis revealed an expected 609-bp product from the
DNA of each patient and from that of normal male
controls. No product was seen in normal female control
lanes. Sequence analyses, using nested PCR primers
flanking the HMG domain spanning 269 bp, revealed
no mutations in either the SRY HMG domain or im-
mediate flanking sequences, in any of the four cell lines
analyzed, compared with normal male HMG sequences
(data not shown).
To define the SRO and to identify resources for map-
ping studies, each patient DNA sample was character-
ized for LOH, by means of 17 highly polymorphicmark-
ers previously mapped to 9p21-pter (table 1). Parental
DNA samples were available for case 7 only. The genetic
and physical maps of distal 9p are shown in figure 1.
Map locations are based on recent data compiled from
Ge´ne´thon and CHLC databases and from mapping re-
ports published elsewhere (Dib et al. 1996; Povey et al.
1997). Results of the analyses reveal that case 7 showed
LOH for marker D9S1779, with neither of the paternal
alleles present in her DNA (table 1 and fig. 2). For
marker D9S1858, both parental samples showed alleles
1 and 2, whereas the proband showed only an allele 2
(fig. 2). Since this marker lies distal to D9S1779, it is
likely that this result is consistent with heterozygous loss,
rather than homozygosity, for allele 2.
Parental samples were not available for cases 4, 8, and
9. Analyses of DNA from each of these individuals, by
means of all 17 microsatellite markers, revealed a single
allele for eight consecutive markers ranging from
D9S1858 through D9S178 (table 1). Although we can-
not distinguish definitively the difference between ho-
mozygosity and heterozygous loss in these individuals,
it is extremely unlikely that all eight consecutivemarkers
would be homozygous in each of the three individuals
by chance alone. If these individuals are in fact hemi-
zygous for these markers, the data suggest that their
deletions are ∼11 cM larger than that seen in case 7 (fig.
1).
To confirm the microsatellite findings and to further
define the smallest region of deletion, we obtained YAC
clones corresponding to the three most distal markers,
for FISH analysis of case 7 and her father: two YACs
represent D9S1858, two are for marker D9S1779, and
three are for D9S1813. The results of the hybridizations
are shown in table 3. To insure that any observed loss
was due to deletion and was not the result of suboptimal
hybridization, an alpha-satellite probe was used as a
control marker for the centromere of chromosome 9.
The normal chromosome 9 also served an internal con-
trol. The failure to observe a hybridization signal on the
distal p arm of one chromosome 9 in multiple cells, for
any given probe, should be detected when it is located
within the site of deletion, indicating LOH. The presence
of a signal on both chromosome 9p regions indicates
that the deletion does not involve that locus. The data
show that case 7 is deleted for the two YACs corre-
sponding to marker D9S1858. In these hybridizations,
signal was observed on the normal chromosome 9 only.
Cells from the proband’s father showed a signal both
on the normal chromosome 9 and on the der(8) chro-
mosome. These data confirm the microsatellite re-
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Figure 1 Physical and genetic maps of distal 9p. Previously
mapped microsatellite markers, with both estimated distance between
markers and map locations, are shown on the left. The map is based
on information from Genome Database and CHLC and on other pre-
viously published data.
Table 2
Summary of Patients with Sex Reversal and Deletions of 9p
Case Reference Karyotypea Originb
1 Jotterand and Juillard (1976) 46,XY,der(9),t(9;13)(p21;q21) Maternal
2 Fryns et al. (1986) 46,XY,der(9),t(3;9)(p21.33;p22.1) Maternal
3 Crocker et al. (1988) 46,XY,der(9),t(7;9)(q31.1;p23) Paternal
4c Hoo et al. (1989) 46,XY,der(9),t(2;9)(p21;p24) De novo
5 Magenis et al. (1990) 46,XY,der(9),t(4;9)(?;p24) Paternal
6 Bennett et al. (1993) 46,XY,del(9)(p23) De novo
7c McDonald et al (1997) 46,XY,der(9),t(8;9)(p21;p24) Paternal
8c Present study 46,XY,der(9),t(9;?15)(p22;?q22.3) Unknown
9c Present study 46,XY,der(9)t(9;11)(p24;?q14.2) Maternal
10 Ogata et al. (1997) 46,XY,del(9)(p23) De novo
a Underlining denotes chromosome 9 breakpoints.
b “Maternal” denotes that the mother is a carrier of the balanced chromosome, and
“Paternal” denotes that the father is a carrier of the balanced chromosome.
c Cell line is currently available for study.
sults—that is, that there is LOH for this marker, as
opposed to homozygosity of this locus (fig. 3A). Hy-
bridization of YAC 747A1, corresponding to marker
D9S1779, to metaphase cells from the proband showed
hybridization both to the normal chromosome 9 and to
the der(9) chromosome (fig. 3B). Hybridization of the
same probe to metaphase cells from her father revealed
hybridization to the normal chromosome 9, to the der(9)
chromosome, and to the der(8) chromosome, indicating
that this clone crosses the translocation breakpoint (fig.
3C). The second D9S1779 YAC clone, 904H6, showed
hybridization both to the normal chromosome 9 and to
the der(9) chromosome, in both the proband and her
father. Each of the three YAC clones corresponding to
marker D9S1813 showed hybridization both to the nor-
mal chromosome 9 and to the der(9) chromosome, in
both the proband and her father. These results coincide
with the microsatellite LOH data.
Discussion
To date, 10 cases, including our patients, who have
9p found in association with XY sex reversal have been
reported (table 2). Cases 1–5 and 7–9 each have con-
current duplication of different DNA segments, resulting
from unbalanced chromosomal translocations. Cases 6
and 10 have de novo deletions of 9p. Of the total 10
cases, 7 exhibit normal female external genitalia, and 3
have ambiguous external genitalia. All patient’s have
varying degrees of internal female structures and mixed
gonadal dysgenesis. Conventional cytogenetic studies in-
dicate that the 9p breakpoints range from band 9p21
to band 9p24, with the SRO spanning 9p24-pter. These
findings suggest that the monosomic region common to
the 10 patients contains a gene(s) responsible for defec-
tive testis formation and, as a result, varying degrees of
impaired male sex development.
Previous studies have shown that mutations in SRY
are found in only a small portion (15%) of sex-reversed
XY females. With few exceptions (McElreavy et al.
1992; Cameron and Sinclair 1997), the majority of mu-
tations have occurred in the conserved HMG domain of
the SRY gene. Therefore, it has been postulated that the
majority of XY females who lack mutations in SRY have
either mutations in or loss of other genes involved in the
testis-determining pathway. To rule out the possibility
that sex reversal in our patients is not due to alterations
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Figure 2 Microsatellite analyses of four 9p cases (lane num-
bers denote case numbers) and the father (lanes F) and mother (lanes
M) of case 7. Genotypes for each individual are listed under their
respective lanes. Marker D9S1779 shows LOH in case 7 and a single
allele in cases 4, 8, and 9. Marker D9S1858, mapping distal to
D9S1779, shows a single allele for each patient.
Table 3
Chromosome 9–Specific YACs Hybridized to Metaphase
Chromosomes from Case 7 and from Her Father
MARKER
STATUS INa
Father Case 7
D9S1858:
765H2  
816E6  
D9S1779:
757A1 b 
904H6  
D9S1813:
803F2  
763G5  
822E7  
a   Hybridization signals on both the normal chromosome 9
and the der(9) chromosome,   hybridization signal only on the
normal chromosome 9.
b YAC crosses the translocation breakpoint.
in the HMG domain of SRY but, rather, results from a
deletion of distal 9p, sequence analysis of the HMG
domain in each individual was performed. Nomutations
were found in any of the four patients. These results
support our hypothesis that either mutation in or loss
of a gene(s) located on chromosomal region 9p is likely
responsible for the XY-female phenotype—and that the
latter is not the result of either mutations in the HMG
domain or loss of function of the SRY gene product.
Microsatellite analyses of markers spanning the distal
short arm of chromosome 9 demonstrate that the gene
necessary for male sex development lies distal to marker
D9S1779. Among our patients, case 7 exhibits the small-
est deletion associated with a sex-reversed phenotype.
LOH studies show that this patient is hemizygous for
both marker D9S1779 andmarker D9S1858. FISH anal-
yses using two YAC clones corresponding to marker
D9S1858 confirmed loss of this locus in case 7. Al-
though, on the basis of microsatellite analysis, this pa-
tient showed a single allele for D9S1779, FISH hybrid-
ization signals for two YAC clones corresponding to this
marker were seen both on the normal chromosome 9
and on the der(9) chromosome, suggesting that the locus
is present. Hybridization of the same two YAC clones
to DNA from the proband’s father showed that one
clone, YAC 757A1, hybridized to the normal chromo-
some 9, to the der(9) chromosome, and to the der(8)
chromosome. The second clone, 904H6, was on the nor-
mal chromosome 9 and the der(9) chromosome only.
These data indicate that clone 757A1 crosses the trans-
location breakpoint and therefore defines the proximal
9p boundary of the sex-determining region. The dis-
crepancy between the microsatellite data and the FISH
results for this marker, in case 7, may indicate that the
D9S1779 repeat sequence is not present on either of the
YAC clones used in the FISH studies. Over time, YACs
have been shown either to recombine out repetitive se-
quences or to delete random regions of insert DNA. If
the repeat lies telomeric to 9p, at the translocation break-
point, and is not present in the YACDNA, hybridization
signals would be expected on both chromosomes 9. Since
YAC 904H6 does not cross the breakpoint in the father
and is present on both copies of chromosome 9 in the
proband, this clone may lie proximal on chromosome
9 and may remain unaffected by the translocation break-
point. A second possibility is that the YAC crosses or is
very close to the translocation breakpoint. Characteriza-
tion of this locus by means of additional physical-map-
ping clones is needed, to clarify these results.
The mechanism by which monosomy 9p gives rise to
a female phenotype in a 46,XY chromosome back-
ground is not clearly understood. In four of the reported
cases, including two of our patients, the deletions were
the result of familial balanced chromosomal transloca-
tions. In three cases the translocation was derived from
the mother, and in three cases the translocation was pa-
ternal in origin. This makes the possibility of imprinting
unlikely. In these instances, it is not known whether sex
reversal is due to monosomy for dosage-sensitive genes
or whether the deletions reveal recessive mutations. Hoo
et al. (1989) have postulated that, since the majority of
patients with “9p syndrome” do not show complete
sex reversal, there may be, on 9p, a recessive gene that
is important in the early development of the testis. The
lack of this gene product in 9p syndrome patients is
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Figure 3 Characterization of case 7 and her father, by FISH. A,
Hybridization of YAC 765H2, representing marker D9S1858, to a
metaphase cell from case 7. A hybridization signal is seen on the
normal chromosome 9 only. B and C, Hybridization of YAC 747A1,
representing marker D9S1779, to a metaphase cell from case 7 (B)
and from her father (C). In the proband, signals are seen on both the
normal chromosome 9 and on the der(9) chromosome. In her father,
signals are seen on the normal chromosome 9, on the der(9) chro-
mosome, and on the der(8) chromosome, indicating that the YAC
crosses the translocation breakpoint. In all cells, an alpha-satellite
probe marks the chromosome 9 centromere.
sufficient to cause a delayed and incomplete testicular
formation, resulting in the absence of influence of male
hormones during the crucial period of sexual differen-
tiation. In contrast, 46,XY sex-reversed individuals may
carry a defective gene on their apparently normal intact
chromosome 9, concurrent with deletion of the healthy
allele on the translocated 9p, resulting in complete sex
reversal. Haploinsufficiency is an alternative explana-
tion, and a dominant mode of expression cannot be ruled
out. Variable penetrance and expressivity could account
for the low frequency of sex reversal due to the deletion,
and for the phenotypic differences between patients. This
has been proposed as a mechanismwhereby some 46,XY
patients with campomelic dysplasia have normal sex de-
velopment whereas others (75%) have some degree of
ambiguous genitalia or sex reversal (Meyer et al. 1997).
One other hypothesis is that sex reversal may be depen-
dent on whether deletions are interstitial or terminal
(Magenis et al. 1990). It has been suggested that phe-
notypic features in monosomy 9p patients—and the as-
sociated sex reversal—are part of a contiguous-gene syn-
drome. Varying clinical findings may be dependent on
which 9p segment is missing, with a critical segment,
leading to testis formation of male genitalia, being in
the most distal region. The vast majority of deletions in
9p syndrome patients are de novo, and deletions must
be interstitial, since, in theory, the chromosome endmust
be capped by the telomere. In those cases, it is possible
that the sex-determining gene, located in close proximity
to the telomere, remains intact and that sex reversal is
not seen even though other malformations may be pres-
ent. In contrast, in all but one individual with sex re-
versal and 9p, the deletions are the result of reciprocal
familial translocations. In those cases, the deleted chro-
mosome 9 is capped by the telomere of the alternate
chromosome involved in the translocation. The chro-
mosome 9 telomere, as well as the putative sex-deter-
mining gene from the der(9) chromosome, presumably
is translocated to the second chromosome involved in
the translocation, which does not segregate to the un-
balanced probands. In these cases, the patients have lost
of one copy of the sex-determining gene, which results
in gonadal dysgenesis. This hypothesis would be con-
sistent with the data presented, which suggest a terminal
location of the putative sex-determining gene, distal to
marker D9S1779.
Few previous studies have defined the location and
physical size of the 9p deletion involved in XY sex re-
versal. Ogata et al. (1997) have mapped the deletion in
one 9p patient to the region distal to marker D9S168,
∼28 Mb from the 9p telomere. Veitia et al. (1997) have
mapped the smallest deletion in their patients as being
distal to marker D9S144, ∼14–21 cM from the telomere,
and Guioli et al. (1997) have mapped the smallest de-
letion in their panel of patients as being betweenmarkers
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D9S1779 and D9S1810, with an estimated physical size
of ∼8–10 cM. In the present study, FISH and LOH stud-
ies of four patients suggest that the smallest common
region is defined by case 7. The deletion breakpoint in
this patient is defined by the balanced translocation in
her father and lies within or distal to marker D9S1779
at band 9p24.3. This defines the proximal locus for fur-
ther physical-mapping efforts. Since the distance of
marker D9S1779 from the 9p telomere is not known,
our efforts to define the exact size of the deletion in case
7—and to identify the putative sex-determining
gene—will rely on the construction of a physical map
spanning this smallest region of deletion. Not only will
the identification of this gene(s) be of significance in the
clinical diagnosis and management of patients with am-
biguous or incomplete gonadal development, but it also
will provide insight into the genetics of sex determina-
tion. Together, these data can be integrated with the cell
biology of gonadal differentiation, to produce a more
complete understanding of this mammalian develop-
mental system.
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